PJ
Payal Jha
About Payal Jha
Data last updated:
Payal Jha is a Director at Ucaili Pharma Private Limited (since 2018) and Director at Mecong Pharma Private Limited (since 2025). The companies operate in Business Services. The largest current company by reported revenue is Ucaili Pharma Private Limited at ₹3.07 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Mar 2018 | 2018 | ₹3.07 Cr (FY 2024) | Active | |
| Director | 26 May 2025 | 2025 | Active |
Board colleagues of Payal Jha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mani Gaurav | 08084302 | Ucaili Pharma Private Limited , Mecong Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Payal Jha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Payal Jha
Payal Jha currently holds 2 directorships: Ucaili Pharma Private Limited (Director, since 13 Mar 2018, revenue ₹3.07 Cr (FY 2024)); Mecong Pharma Private Limited (Director, since 26 May 2025).
Payal Jha was first appointed on 13 Mar 2018 as Director at Ucaili Pharma Private Limited. The most recent appointment on record is 26 May 2025 at Mecong Pharma Private Limited.
The current boards of Payal Jha's companies include Mani Gaurav (Ucaili Pharma Private Limited).